Holen Sie sich die Stockscreener-App
284.85
1.94%
-5.64
Vorhandelsmarkt:
284.88
0.03
+0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$290.49
Offen:
$291.68
24-Stunden-Volumen:
1.40M
Relative Volume:
0.84
Marktkapitalisierung:
$75.35B
Einnahmen:
$278.13B
Nettoeinkommen (Verlust:
$6.74B
KGV:
12.07
EPS:
23.6047
Netto-Cashflow:
$7.66B
1W Leistung:
-4.35%
1M Leistung:
+0.98%
6M Leistung:
+1.59%
1J Leistung:
-5.07%
1-Tages-Spanne:
$284.66
$293.21
1-Wochen-Bereich:
$278.86
$293.21
52-Wochen-Spanne:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
284.85 | 75.35B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
431.31 | 391.69B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
108.08 | 137.90B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
389.09 | 84.38B | 201.11B | 4.95B | 6.29B | 22.50 |
HUM
Humana Inc
|
397.60 | 47.74B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Cigna Group (CI) Could Be 16% Below Fair Value Following Its Recent Pullback - simplywall.st
Cigna Group To Go Ex-Dividend On September 8th, 2026 With 1.56 USD Dividend Per Share - 富途牛牛
Cigna Group Keeps Quarterly Dividend at $1.56 a Share, Payable Sept. 23 to Shareholders of Record on Sept. 8 - marketscreener.com
Cigna Group Declares Quarterly Dividend - TradingView
Cigna declares $1.56 per share dividend payable September 23, 2026 - Pluang
Cigna Group declares $1.56 quarterly dividend per share - Investing.com
Cigna Group stock underperforms Wednesday when compared to competitors - MarketWatch
Cigna Corp. (CI) Declares $1.56 Quarterly Dividend; 2.2% Yield - StreetInsider
Cigna sets Sept. 23 payment date for $1.56 dividend - Stock Titan
Cigna Dealt Three Surprise Billing Losses to Doctors in Court - Bloomberg Law News
Enterprise value to revenue forward of Cigna Group – LSX:A2PA9L - TradingView
A3LUJM Bond Profile — Key Metrics - TradingView
Cigna Group stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Cigna Group stock trades steadily as health benefits growth supports margins - Ad-hoc-news.de
Prediction: U.S. Value Stocks Will Outperform for 10 Years. Which ETFs Should You Buy? - The Motley Fool
Impact in action: The Cigna Group’s commitment to better health for all - The Cigna Group Newsroom
Cigna Group stock steadies as higher 2024 guidance follows strong first quarter - Ad-hoc-news.de
Cigna’s Express Scripts Pressured Over TRICARE Contract in Senate Hearing - HEALTH CARE un-covered
Cigna Group stock trades steady as earnings growth and buybacks support valuation - ad-hoc-news.de
Cigna (CI) Stock May Trade At A Discount Despite A 33% Five Year Gain - simplywall.st
ETFs Investing in Cigna Group Stocks - TradingView
Cigna Group (CI) Faces A Valuation Test, Is The Recent Pullback A Buying Opportunity? - Yahoo Finance
Cigna Group stock holds gains as higher premiums lift 2024 outlook - ad-hoc-news.de
Cigna Group (CI) Revenue BreakdownMain Composition - Moomoo
Cigna Group stock trades steadily as medical benefits earnings and guidance frame valuation - Ad-hoc-news.de
Volunteer of the Year: Diana Lenis turns empathy into action for families affected by rare disease - The Cigna Group Newsroom
3rd Circ. Partly Revives Hospitals' ERISA Suit Against Cigna - Law360
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
UnitedHealth Rally Boosts Healthcare ETFs Despite Medicare LossesUnitedHealth Group (NYSE:UNH), State - Benzinga
What Does Representative Moskowitz's Cigna Sale Signal - Kavout | AI
(CI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Cigna Group stock holds steady as a major U.S. health insurer with diversified benefits business - Ad-hoc-news.de
What CHROs need to know about health care affordability - Cigna Healthcare Newsroom
Cigna Group at TD Cowen Healthcare Conference Transcript - GuruFocus
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's - StockStory
Cigna Group Announces New CEO; Wall Street Admits Surprise But Remains Bullish - Stocktwits
Lawmakers Target the Power of Health Insurance Giants - The New York Times
Cigna Group (CI) Turns To AI Pharmacy Care On A Narrative That Still Looks Undervalued - simplywall.st
Daily Brief Health Care: Apnimed, Cigna Group, Exelixis Inc, Scribe Therapeutics, CSPC Pharmaceutical and more - Smartkarma
Why Cigna (CI) Stock Is Up Today - Yahoo Finance
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
Why The Cigna Group (CI) Stock Is Up Today - Moomoo
Cigna’s $30.35 EPS Floor: Can Evernorth Offset Pharmacy Margin Pressure? - Smartkarma
Josh Michelson Appointed Executive Vice President, Chief Strategy and Innovation Officer at The Cigna Group - hrtoday.in
The Cigna Group (CI) Stock Analysis: Exploring a Potential 16% Upside for Healthcare Investors - DirectorsTalk Interviews
Cigna Group stock holds steady on its business mix - ad-hoc-news.de
RBC Capital Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $337 - Moomoo
Built with America: The Cigna Group’s 230-year history of innovation in service of customers - The Cigna Group Newsroom
Cigna Group (NYSE: CI) officer Bryan Holgerson details stock, 401(k) and option positions in Form 3 - Stock Titan
Cigna Group (NYSE: CI) officer Adam Kautzner details stock and option holdings - Stock Titan
Cigna Group (NYSE: CI) officer Jason Sadler reports share and option holdings - Stock Titan
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
1.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):